Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 43547-314

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 43547-314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5a5eca60 Figure 01

A line graph showing the percentage of patients with systolic blood pressure (SBP) under 140 mmHg across different baseline SBP levels (140–180 mmHg). It compares four groups: Valsartan-HCTZ 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, illustrating their effects on achieving SBP below 140 mmHg.*

FDA Label Image

5a5eca60 Figure 02

A line graph depicting the percentage of patients with diastolic blood pressure (DBP) below 90 mmHg against baseline DBP ranging from 90 to 110 mmHg. It compares four groups: Valsartan-HCTZ 320/25 mg (black circles), Valsartan 320 mg (white triangles), Hydrochlorothiazide 25 mg (grey squares), and placebo (grey crosses), showing higher effectiveness in the combination treatment group.*

FDA Label Image

5a5eca60 Figure 03

A line graph displaying the percentage of patients achieving systolic blood pressure (SBP) under 130 mmHg versus baseline SBP levels (140-180 mmHg). Four data series are shown: Valsartan-HCTZ 320/25 mg combination, Valsartan 320 mg alone, Hydrochlorothiazide 25 mg alone, and Placebo. The graph illustrates comparative efficacy of these treatments in reducing SBP.*

FDA Label Image

5a5eca60 Figure 04

A line graph depicting the percentage of patients with diastolic blood pressure (DBP) under 80 mmHg versus baseline DBP (90-110 mmHg). Four groups are shown: Valsartan-HCTZ 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The Valsartan-HCTZ combination group shows the highest percentage achieving DBP under 80 mmHg, followed by Valsartan, Hydrochlorothiazide, and Placebo groups.*

FDA Label Image

5a5eca60 Figure 05

Chemical structure diagram of valsartan, one of the active ingredients in valsartan and hydrochlorothiazide tablets. The structure shows molecular components and bonds typical for valsartan.*

FDA Label Image

5a5eca60 Figure 06

Chemical structure diagram of the active ingredient hydrochlorothiazide, showing its molecular composition and bonds, including sulfur, chlorine, nitrogen, and oxygen atoms.*

FDA Label Image

5a5eca60 Figure 07

Label for Valsartan and Hydrochlorothiazide Tablets, USP, 80 mg/12.5 mg film-coated tablets. The label indicates a bottle containing 30 tablets, distributed by Solco Healthcare US, LLC. It includes storage instructions, manufacturer information (Zhejiang Huahai Pharmaceutical Co., Ltd., China), and a barcode on the left side.*

FDA Label Image

5a5eca60 Figure 08

Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/12.5 mg, film-coated oral tablets. The package contains 30 tablets. The label includes storage instructions, manufacturer Zhejiang Huahai Pharmaceutical Co., Ltd. (China), and distributor Solco Healthcare US, LLC (Somerset, NJ). The label features the Solco Healthcare logo and an NDC number 43547-312-03.*

FDA Label Image

5a5eca60 Figure 09

The label for Valsartan and Hydrochlorothiazide Tablets, USP, 160 mg/25 mg film-coated tablets supplied by Solco Healthcare US, LLC. The label includes dosage strength, quantity of 30 tablets, and storage instructions. The product is for prescription use only and manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd.*

FDA Label Image

5a5eca60 Figure 10

Label for Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/12.5 mg, film-coated tablets. The label indicates a package containing 30 tablets and includes manufacturer information for Zhejiang Huahai Pharmaceutical Co., Ltd., and distributor Solco Healthcare US, LLC. Storage and handling instructions are also printed.*

FDA Label Image

5a5eca60 Figure 11

Label for Valsartan and Hydrochlorothiazide Tablets USP, 320 mg/25 mg, film-coated tablets. The label indicates 30 tablets per container, manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd., and distributed by Solco Healthcare US, LLC. Storage instructions and manufacturing details are also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.